You have 9 free searches left this month | for more free features.

Ophthalmic solution

Showing 1 - 25 of 5,694

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Healthy Adult Males Volunteers Trial in Osaka (STN1012600 ophthalmic solution 0.002%)

Recruiting
  • Healthy Adult Males Volunteers
  • STN1012600 ophthalmic solution 0.002%
  • Osaka, Japan
    Medical Corporation Heishinkai OPHAC Hospital
Jun 6, 2023

Dry Eye Syndromes, Dry Eye Disease, Kerato Conjunctivitis Sicca Trial (5% Tavilermide ophthalmic solution, Vehicle ophthalmic

Not yet recruiting
  • Dry Eye Syndromes
  • +2 more
  • 5% Tavilermide ophthalmic solution
  • Vehicle ophthalmic solution
  • (no location specified)
Apr 27, 2023

Dry Eye Syndromes Trial in Andover (IC265 Ophthalmic Solution 1%, Placebo Ophthalmic Solution (Vehicle))

Not yet recruiting
  • Dry Eye Syndromes
  • IC265 Ophthalmic Solution 1%
  • Placebo Ophthalmic Solution (Vehicle)
  • Andover, Massachusetts
    Iacta Selected Site
Aug 8, 2023

Corneal Epithelial Degeneration Trial in Cypress (TTHX1114(NM141) Ophthalmic Solution)

Recruiting
  • Corneal Epithelial Degeneration
  • TTHX1114(NM141) Ophthalmic Solution
  • Cypress, California
    Trefoil Clinical Site #132
Mar 3, 2023

Dry Eye Disease Trial in Bellaire (Topical spironolactone ophthalmic solution, 0.005 mg/cc, Placebo)

Not yet recruiting
  • Dry Eye Disease
  • Topical spironolactone ophthalmic solution, 0.005 mg/cc
  • Placebo
  • Bellaire, Texas
    Richard W Yee, MD PLLC
Aug 16, 2023

Allergic Conjunctivitis Trial in Adelaide (MDI-1228_mesylate Ophthalmic Solution, Placebo)

Recruiting
  • Allergic Conjunctivitis
  • MDI-1228_mesylate Ophthalmic Solution
  • Placebo
  • Adelaide, South Australia, Australia
    CMAX Clinical Research
Jul 24, 2023

Brimonidine Tartrate 0.025%/Ketotifen Fumarate 0.035%

Not yet recruiting
  • Allergic Conjunctivitis
  • rimonidine Tartrate 0.025%/Ketotifen Fumarate 0.035% Ophthalmic Solution (Combo)
  • Vehicle of brimonidine tartrate 0.025%/ketotifen fumarate 0.035% ophthalmic solution
  • (no location specified)
Apr 4, 2023

Open Angle Glaucoma, Ocular Hypertension Trial in Newport Beach (Travoprost Ophthalmic Topical Cream low-dose, Travoprost

Not yet recruiting
  • Open Angle Glaucoma
  • Ocular Hypertension
  • Travoprost Ophthalmic Topical Cream low-dose
  • +4 more
  • Newport Beach, California
    Glaukos Clinical Study Site
Nov 22, 2023

Dry Eye Disease Trial in Andover (Reproxalap Ophthalmic Solution (0.25%), Placebo Comparator)

Completed
  • Dry Eye Disease
  • Reproxalap Ophthalmic Solution (0.25%)
  • Placebo Comparator
  • Andover, Massachusetts
    Andover Eye Associates
Jan 24, 2023

Open Angle Glaucoma Trial (NCX 470, Placebo)

Not yet recruiting
  • Open Angle Glaucoma
  • NCX 470
  • Placebo
  • (no location specified)
Jul 6, 2023

0.5% Moxifloxacin Hydrochloride Ophthalmic Solution in

Not yet recruiting
  • Post Operative Endophthalmitis
  • Moxifloxacin hydrochloride ophthalmic solution
  • (no location specified)
Jan 11, 2023

Cataract, Glaucoma, Ocular Hypertension Trial in Glendale (Bimatoprost Implant System (High Dose), Bimatoprost Implant System

Recruiting
  • Cataract
  • +2 more
  • Bimatoprost Implant System (High Dose)
  • +4 more
  • Glendale, Arizona
    Arizona Advanced Eye Research Institute
Nov 8, 2023

Primary Open Angle Glaucoma (POAG), Primary Open Angle Glaucoma of Both Eyes, Primary Open-Angle Glaucoma, Unspecified Eye Trial

Not yet recruiting
  • Primary Open Angle Glaucoma (POAG)
  • +3 more
  • Experimental: QLS-111 ophthalmic solution, (0.015%)
  • +4 more
  • (no location specified)
Aug 30, 2023

Rhegmatogenous Retinal Detachment - Macula Off Trial (ONL1204 Ophthalmic Solution, Sham treatment)

Not yet recruiting
  • Rhegmatogenous Retinal Detachment - Macula Off
  • ONL1204 Ophthalmic Solution
  • Sham treatment
  • (no location specified)
Feb 15, 2023

Presbyopia Trial in Glendale, Memphis (0.1% STN1013600 ophthalmic solution, 0.3% STN1013600 ophthalmic solution, Placebo)

Recruiting
  • Presbyopia
  • 0.1% STN1013600 ophthalmic solution
  • +2 more
  • Glendale, California
  • +1 more
Jan 12, 2023

Dry Eye Disease Trial in Durham (SY-201 Ophthalmic Solution 2.0%, SY-201 Ophthalmic Solution 1.0%, SY-201 Ophthalmic Solution

Recruiting
  • Dry Eye Disease
  • SY-201 Ophthalmic Solution 2.0%
  • +3 more
  • Durham, North Carolina
    Lexitas
Jul 27, 2022

Allergic Conjunctivitis Trial in Phoenix, Andover, Memphis (Brimonidine tartrate 0.025% / ketotifen fumarate 0.035% combo,

Not yet recruiting
  • Allergic Conjunctivitis
  • Brimonidine tartrate 0.025% / ketotifen fumarate 0.035% combo
  • +3 more
  • Phoenix, Arizona
  • +2 more
Nov 9, 2022

Neurotrophic Keratitis Trial (BRM424 Ophthalmic Solution, Vehicle)

Not yet recruiting
  • Neurotrophic Keratitis
  • (no location specified)
Jun 28, 2023

Open Angle Glaucoma, Ocular Hypertension Trial in Japan (STN1012600 ophthalmic solution 0.002%, STN1012600 ophthalmic solution

Recruiting
  • Open Angle Glaucoma, Ocular Hypertension
  • STN1012600 ophthalmic solution 0.002%
  • STN1012600 ophthalmic solution 0.002% and Timolol ophthalmic solution 0.5%
  • Aichi, Japan
  • +15 more
Aug 16, 2022

Epiphora, Dacryostenosis, Dacryocystitis Trial in New Orleans (Proparacaine Hydrochloride ophthalmic solution, USP 0.5%,

Recruiting
  • Epiphora
  • +2 more
  • Proparacaine Hydrochloride ophthalmic solution, USP 0.5%
  • Balanced salt solution
  • New Orleans, Louisiana
    Louisiana State University Health Sciences Center
Dec 15, 2022

Dry Eye Trial in Mississauga (Reproxalap Ophthalmic Solution (0.25%), Xiidra® (5% lifitegrast ophthalmic solution))

Completed
  • Dry Eye
  • Reproxalap Ophthalmic Solution (0.25%)
  • Xiidra┬« (5% lifitegrast ophthalmic solution)
  • Mississauga, Ontario, Canada
    Cliantha Research
Sep 26, 2022

Acute Infectious Keratoconjunctivitis Trial (INV-102, Vehicle)

Not yet recruiting
  • Acute Infectious Keratoconjunctivitis
  • (no location specified)
Jan 12, 2023

Preservative-Free Ophthalmic Solution in Ocular Dryness

Active, not recruiting
  • Dry Eye Syndromes
  • Eyestil SYNFO
  • Alicante, Spain
  • +3 more
Mar 20, 2023

Seasonal Allergic Conjunctivitis Trial in Andover, Memphis (Brimonidine Tartrate 0.025%/ Ketotifen Fumarate 0.035% Ophthalmic

Not yet recruiting
  • Seasonal Allergic Conjunctivitis
  • Brimonidine Tartrate 0.025%/ Ketotifen Fumarate 0.035% Ophthalmic Solution
  • +3 more
  • Andover, Massachusetts
  • +1 more
Nov 9, 2022

Anesthesia, Local Trial in McAllen (AG-920, Proparacaine Ophthalmic)

Completed
  • Anesthesia, Local
  • McAllen, Texas
    American Genomics Site 2
Sep 21, 2022